Hims & Hers Health EPS - Earnings per Share 2020-2024 | HIMS
Hims & Hers Health annual and quarterly earnings per share history from 2020 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Hims & Hers Health EPS for the quarter ending December 31, 2024 was $0.10, a 900% increase year-over-year.
- Hims & Hers Health EPS for the twelve months ending December 31, 2024 was $0.53, a 581.82% decline year-over-year.
- Hims & Hers Health 2024 annual EPS was $0.53, a 581.82% decline from 2023.
- Hims & Hers Health 2023 annual EPS was $-0.11, a 65.63% decline from 2022.
- Hims & Hers Health 2022 annual EPS was $-0.32, a 44.83% decline from 2021.
| Hims & Hers Health Annual EPS | |
|---|---|
| 2024 | $0.53 |
| 2023 | $-0.11 |
| 2022 | $-0.32 |
| 2021 | $-0.58 |
| 2020 | $-0.51 |
| 2019 | $-2.07 |
| 2018 | $0.00 |
| Hims & Hers Health Quarterly EPS | |
|---|---|
| 2024-12-31 | $0.10 |
| 2024-09-30 | $0.32 |
| 2024-06-30 | $0.06 |
| 2024-03-31 | $0.05 |
| 2023-12-31 | $0.01 |
| 2023-09-30 | $-0.04 |
| 2023-06-30 | $-0.03 |
| 2023-03-31 | $-0.05 |
| 2022-12-31 | $-0.05 |
| 2022-09-30 | $-0.09 |
| 2022-06-30 | $-0.10 |
| 2022-03-31 | $-0.08 |
| 2021-12-31 | $-0.11 |
| 2021-09-30 | $-0.08 |
| 2021-06-30 | $-0.05 |
| 2021-03-31 | $-0.34 |
| 2020-12-31 | $-0.15 |
| 2020-09-30 | $-0.16 |
| 2020-06-30 | $-0.03 |
| 2020-03-31 | $-0.17 |
| 2019-12-31 | $0.00 |
| 2019-09-30 | $-0.09 |
| 2019-06-30 | $-0.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $6.050B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |